Acinetobacter baumannii infections pose a grave risk to hospitalized patients due to their resistance to antimicrobial substances. This necessitates the urgent development of novel therapeutic strategies. By comparing the genetic repertoire between pathogenic and non-pathogenic Acinetobacter we discovered genetic traits that offer surprising insights into how the pathogen interacts with humans. However, much remains to be learned about the pathogen’s phenotypic diversity.